170 related articles for article (PubMed ID: 12196532)
1. Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations.
Abbey SE; Potter LR
J Biol Chem; 2002 Nov; 277(45):42423-30. PubMed ID: 12196532
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
3. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue: a possible mechanism of heterologous desensitization.
Potter LR; Hunter T
J Biol Chem; 2000 Oct; 275(40):31099-106. PubMed ID: 10915802
[TBL] [Abstract][Full Text] [Related]
5. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
Abbey SE; Potter LR
Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B).
Abbey-Hosch SE; Cody AN; Potter LR
Hypertension; 2004 May; 43(5):1103-9. PubMed ID: 15037564
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclic GMP and calcineurin in homologous and heterologous desensitization of natriuretic peptide receptor-A.
Fortin Y; De Léan A
Can J Physiol Pharmacol; 2006 May; 84(5):539-46. PubMed ID: 16902599
[TBL] [Abstract][Full Text] [Related]
9. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of NPR-B/GC-B by protein kinase c and calcium.
Abbey-Hosch SE; Smirnov D; Potter LR
Biochem Pharmacol; 2005 Sep; 70(5):686-94. PubMed ID: 16005434
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
12. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
Potter LR
Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
[TBL] [Abstract][Full Text] [Related]
14. Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta 1 in cultured aortic smooth muscle cells.
Fujio N; Gossard F; Bayard F; Tremblay J
Hypertension; 1994 Jun; 23(6 Pt 2):908-13. PubMed ID: 7911451
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ANP receptor-mediated cGMP accumulation by atrial natriuretic peptides and vasopressin in A10 vascular smooth muscle cells.
Bellemann P; Neuser D
J Recept Res; 1988; 8(1-4):407-17. PubMed ID: 2898530
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta.
Drewett JG; Fendly BM; Garbers DL; Lowe DG
J Biol Chem; 1995 Mar; 270(9):4668-74. PubMed ID: 7876238
[TBL] [Abstract][Full Text] [Related]
17. Presence of functional type B natriuretic peptide receptor in human ocular cells.
Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.
Hutchinson HG; Trindade PT; Cunanan DB; Wu CF; Pratt RE
Cardiovasc Res; 1997 Jul; 35(1):158-67. PubMed ID: 9302360
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
20. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
